
Please try another search
WASHINGTON (Reuters) - U.S. Trade Representative Katherine Tai discussed increasing COVID-19 vaccine production in a virtual meeting on Tuesday with an executive with drugmaker Novavax (NASDAQ:NVAX), Tai's office said in a statement.
Tai and Novavax Executive Vice President John Trizzino also discussed a proposal before the World Trade Organization to waive certain intellectual property rights in response to the coronavirus pandemic, the USTR statement said.
"Ambassador Tai sought Mr. Trizzino's views on steps Novavax is taking to quickly increase equitable production and distribution of vaccines in the United States and around the world," the statement said.
Novavax's COVID-19 vaccine is not currently authorized for use in the United States.
WTO members are due to discuss a proposal by India and South Africa to waive certain provisions of the WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights on April 30, but the United States and a few other big countries have blocked such a move.
Democratic lawmakers, civil society groups, and 60 former heads of state and 100 Nobel Prize winners have urged President Joe Biden to back the waiver.
Shares of Novavax surged 16% in extended trading on Tuesday after Biden said the United States was planning to share COVID-19 vaccines with countries in need of aid.
The company is expected to report data from its ongoing large, late-stage study in the United States and Mexico during the second quarter of this year.
Tai held virtual meetings on Monday with vaccine makers Pfizer (NYSE:PFE) and AstraZeneca (NASDAQ:AZN).
Novavax Chief Executive Stanley Erck met with South Korean President Moon Jae-in on Tuesday and said he was in talks with SK bioscience, the vaccine arm of SK Chemicals, to extend production and tech transfer agreements until 2022.
SK bioscience plans to start producing the Novavax COVID-19 vaccines as soon as the approval comes and manufacture 40 million doses to supply South Korea.
By Andrew Galbraith SHANGHAI (Reuters) - Asian shares jumped in early trade on Friday after China cut a key lending benchmark to support a slowing economy, but a gauge of global...
By Manas Mishra and Michael Erman (Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended the COVID-19 vaccine booster for children ages 5 to...
By Gina Lee Investing.com – Asia Pacific stocks were up on Friday morning, with U.S. futures also climbing higher as a measure of calm returned to markets. However, concerns of an...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.